130 related articles for article (PubMed ID: 16315929)
41. Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer.
Takahashi I; Emi Y; Kakeji Y; Tokunaga E; Ushiro S; Oki E; Watanabe M; Baba H; Maehara Y
Oncol Rep; 2006 Apr; 15(4):849-54. PubMed ID: 16525670
[TBL] [Abstract][Full Text] [Related]
42. [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Kobayashi K; Ueki K; Wakakuwa R; Ishizuka D; Tada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1147-50. PubMed ID: 16912537
[TBL] [Abstract][Full Text] [Related]
43. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma.
Ajani JA
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985
[TBL] [Abstract][Full Text] [Related]
44. [Complete response in an elderly patient with advanced gastric cancer treated with TS-1].
Ijuin H; Tokitou D; Adachi E; Imamura K; Imamura S; Arima T; Atsuchi Y; Nakano K; Kotobuki S
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2165-8. PubMed ID: 15628764
[TBL] [Abstract][Full Text] [Related]
45. [Two cases of advanced gastric cancer with peritoneal dissemination acquired long-term response three years or more by postoperative treatment with oral anticancer drug TS-1].
Shikano T; Koshikawa K; Kiriyama K; Wada M; Taniguchi K; Suenaga H
Gan To Kagaku Ryoho; 2006 Jan; 33(1):87-90. PubMed ID: 16410704
[TBL] [Abstract][Full Text] [Related]
46. The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors.
Peters GJ; Noordhuis P; Van Groeningen CJ; Giaccone G; Holwerda U; Voorn D; Schrijvers A; Schornagel JH; Beijnen JH; Fumoleau P; Schellens JH
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4072-6. PubMed ID: 15217941
[TBL] [Abstract][Full Text] [Related]
47. [A case of malignant gastric outlet stenosis palliated with self-expandable metallic stent and responding to TS-1, an oral fluorouracil derivative].
Tokumitsu Y; Nagano C; Matsuura T; Seo M; Mitsugi K
Gan To Kagaku Ryoho; 2004 Jan; 31(1):99-102. PubMed ID: 14750331
[TBL] [Abstract][Full Text] [Related]
48. [Support of TS-1, 5-FU preparation containing potent DPD inhibitor by determination of urinary uracil/serum 5-FU clearance].
Morimoto S; Shono Y; Tsuji T; Makihara K; Kawato N; Hachino Y; Mishima H; Tsujinaka T; Tabuse K
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2083-9. PubMed ID: 14712769
[TBL] [Abstract][Full Text] [Related]
49. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
[TBL] [Abstract][Full Text] [Related]
50. [A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
Jingu K; Sasagawa K; Kagaya A; Ochiai T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2117-20. PubMed ID: 16352940
[TBL] [Abstract][Full Text] [Related]
51. [Adverse reactions to TS-1 for outpatients with recurrent head and neck cancer].
Nishino H; Shinozaki T; Ishikawa K; Tanaka H; Ichimura K
Gan To Kagaku Ryoho; 2002 Nov; 29(11):2019-23. PubMed ID: 12465408
[TBL] [Abstract][Full Text] [Related]
52. Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study.
Booka E; Imamura CK; Takeuchi H; Hamamoto Y; Gomi D; Mizukami T; Ichiyama T; Tateishi K; Takahashi T; Kawakubo H; Soejima K; Boku N; Tanigawara Y; Kitagawa Y
Gastric Cancer; 2016 Jul; 19(3):876-86. PubMed ID: 26304171
[TBL] [Abstract][Full Text] [Related]
53. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
Yoshisue K; Masuda H; Matsushima E; Ikeda K; Nagayama S; Kawaguchi Y
Drug Metab Dispos; 2000 Oct; 28(10):1162-7. PubMed ID: 10997934
[TBL] [Abstract][Full Text] [Related]
54. [A case of lymph node metastasis after total laryngectomy successfully treated with chemoradiotherapy with TS-1].
Suzuki S; Yoshihara T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1945-7. PubMed ID: 14650964
[TBL] [Abstract][Full Text] [Related]
55. Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.
Yamagata S; Nakata B; Hirakawa K
Oncol Rep; 2004 Nov; 12(5):973-8. PubMed ID: 15492780
[TBL] [Abstract][Full Text] [Related]
56. [Pharmacoeconomic study of chemotherapy for gastric cancer: analysis of medical costs for oral fluoropyrimidine TS-1 and conventional i.v therapy].
Tanaka K; Kaetsu T; Suzuki S; Kusano M; Yajima S; Sakamaki H; Ikeda S; Ikegami N; Murayama J
Gan To Kagaku Ryoho; 2003 Jan; 30(1):73-80. PubMed ID: 12557708
[TBL] [Abstract][Full Text] [Related]
57. [TS-1 therapy via intestinal catheter used for tube feeding in a patient with gastric cancer after total gastrectomy].
Hagiike M; Tsuboi Y; Akamoto S; Yachida S; Izuishi K; Karasawa Y; Goda F; Okada S; Usuki H; Maeta H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1033-6. PubMed ID: 16044968
[TBL] [Abstract][Full Text] [Related]
58. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.
Sakata Y; Ohtsu A; Horikoshi N; Sugimachi K; Mitachi Y; Taguchi T
Eur J Cancer; 1998 Oct; 34(11):1715-20. PubMed ID: 9893658
[TBL] [Abstract][Full Text] [Related]
59. [Case study--an elderly patient with Stage IV advanced gastric cancer achieved good performance status (PS) without subjective symptoms for more than two years by chemotherapy].
Matsubara T; Yoshizawa Y; Sasaya S; Nemoto H; Aita K; Goto T; Shirahata A; Sanada Y
Gan To Kagaku Ryoho; 2006 Mar; 33(3):381-4. PubMed ID: 16531724
[TBL] [Abstract][Full Text] [Related]
60. [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Yamada Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():37-41. PubMed ID: 16897970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
